Takimoto M - Search Results

1

Adenovirus-mediated gene therapy for bladder cancer in an orthotopic model using a dominant negative H-ras mutant.

Watanabe T, Shinohara N, Sazawa A, Takimoto M, Hashimoto A, Koyanagi T, Kuzumaki N. Watanabe T, et al. Among authors: takimoto m. Int J Cancer. 2001 Jun 1;92(5):712-7. doi: 10.1002/1097-0215(20010601)92:5<712::aid-ijc1242>3.0.co;2-z. Int J Cancer. 2001. PMID: 11340577

2

Gelsolin gene silencing involving unusual hypersensitivities to dimethylsulfate and KMnO4 in vivo footprinting on its promoter region.

Haga K, Fujita H, Nomoto M, Sazawa A, Nakagawa K, Harabayashi T, Shinohara N, Takimoto M, Nonomura K, Kuzumaki N. Haga K, et al. Among authors: takimoto m. Int J Cancer. 2004 Oct 10;111(6):873-80. doi: 10.1002/ijc.20348. Int J Cancer. 2004. PMID: 15300799 Free article.

3

Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y.

Senmaru N, Shichinohe T, Takeuchi M, Miyamoto M, Sazawa A, Ogiso Y, Takahashi T, Okushiba S, Takimoto M, Kato H, Kuzumaki N. Senmaru N, et al. Among authors: takimoto m. Int J Cancer. 1998 Oct 29;78(3):366-71. doi: 10.1002/(SICI)1097-0215(19981029)78:3<366::AID-IJC18>3.0.CO;2-4. Int J Cancer. 1998. PMID: 9766573 Free article.

4

The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice.

Takeuchi M, Shichinohe T, Senmaru N, Miyamoto M, Fujita H, Takimoto M, Kondo S, Katoh H, Kuzumaki N. Takeuchi M, et al. Among authors: takimoto m. Gene Ther. 2000 Mar;7(6):518-26. doi: 10.1038/sj.gt.3301125. Gene Ther. 2000. PMID: 10757026

5

siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells.

Tanaka H, Shirkoohi R, Nakagawa K, Qiao H, Fujita H, Okada F, Hamada J, Kuzumaki S, Takimoto M, Kuzumaki N. Tanaka H, et al. Among authors: takimoto m. Int J Cancer. 2006 Apr 1;118(7):1680-91. doi: 10.1002/ijc.21559. Int J Cancer. 2006. PMID: 16217750 Free article.

6

[Strategies for the detection and the identification of tumor suppressor genes].

Takimoto M, Kuzumaki N. Takimoto M, et al. Nihon Rinsho. 1995 Nov;53(11):2666-71. Nihon Rinsho. 1995. PMID: 8538023 Review. Japanese.

7

Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers.

Takimoto M, Wei G, Dosaka-Akita H, Mao P, Kondo S, Sakuragi N, Chiba I, Miura T, Itoh N, Sasao T, Koya RC, Tsukamoto T, Fujimoto S, Katoh H, Kuzumaki N. Takimoto M, et al. Br J Cancer. 2002 Jun 5;86(11):1757-62. doi: 10.1038/sj.bjc.6600328. Br J Cancer. 2002. PMID: 12087463 Free PMC article.

8

Molecular analysis of the GCF gene identifies revisions to the cDNA and amino acid sequences(1).

Takimoto M, Mao P, Wei G, Yamazaki H, Miura T, Johnson AC, Kuzumaki N. Takimoto M, et al. Biochim Biophys Acta. 1999 Oct 6;1447(1):125-31. doi: 10.1016/s0167-4781(99)00127-x. Biochim Biophys Acta. 1999. PMID: 10500253

9

Suppressive effect of modified dominant negative RAS mutant on human cancer by gene transfer with non-viral vector.

Suzuki H, Kuzumaki S, Nakagawa K, Takimoto M, Shichinohe T. Suzuki H, et al. Among authors: takimoto m. Cancer Biol Ther. 2006 Nov;5(11):1487-91. doi: 10.4161/cbt.5.11.3298. Epub 2006 Nov 19. Cancer Biol Ther. 2006. PMID: 17102594 Free article.

10

Re-examination of 5' end of cDNA of transcription factor GCF.

Takimoto M, Mao P, Wei G, Johnson AC, Kuzumaki N. Takimoto M, et al. Nucleic Acids Symp Ser. 1997;(37):121-2. Nucleic Acids Symp Ser. 1997. PMID: 9586029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters